MediFind
Condition

Onchocerciasis

Latest Research

Latest Advance
Study
  • Condition: Onchocerciasis
  • Journal: Parasites & vectors
  • Treatment Used: Ivermectin
  • Number of Patients: 0
  • Published —
This study tested the safety and efficacy of using ivermectin to treat patients with onchocerciasis.
Latest Advance
Study
  • Condition: Tropical Diseases
  • Journal: The Journal of antimicrobial chemotherapy
  • Treatment Used: High-dose Ivermectin
  • Number of Patients: 0
  • Published —
In this study, researchers evaluated the safety high-dose ivermectin for the treatment of of tropical diseases such as scabies, soil-transmitted worms, and malaria.
Latest Advance
Study
  • Condition: Onchocerciasis in the Democratic Republic of Congo
  • Journal: BMC pharmacology & toxicology
  • Treatment Used: Ivermectin (CDTI)
  • Number of Patients: 15552588
  • Published —
This study determined the frequency of post-ivermectin (CDTI) severe adverse effects (SAE) as well as factors associated with the occurrence of severe adverse effects in the treatment of onchocerciasis (river blindness).
Latest Advance
Study
  • Condition: Adults with Wuchereria bancrofti infection in Côte d'Ivoire
  • Journal: PLoS neglected tropical diseases
  • Treatment Used: Diethylcarbamazine, albendazole and ivermectin
  • Number of Patients: 56
  • Published —
The study researched the effects of diethylcarbamazine, albendazole and ivermectin for adults with Wuchereria bancrofti infection in Côte d'Ivoire.
Latest Advance
Study
  • Condition: Trichuris trichiura infections
  • Journal: The Lancet. Infectious diseases
  • Treatment Used: Moxidectin alone versus moxidectin co-administered with albendazole and tribendimidine versus albendazole plus oxantel pamoate
  • Number of Patients: 701
  • Published —
This study assessed the efficacy of moxidectin alone and in co-administrations against trichuris trichiura infections.
Latest Advance
Study
  • Condition: Uncomplicated Malaria (IVERMAL)
  • Journal: The Lancet. Infectious diseases
  • Treatment Used: High-dose ivermectin when co-administered with dihydroartemisinin-piperaquine
  • Number of Patients: 141
  • Published —
This study was aimed at establishing the safety, tolerability, and mosquitocidal efficacy of three day course of high-dose ivermectin, co administered with a standard malaria treatment.